Prospective Study Finds Potential Utility of MeMed’s Host Immune Technology for Personalizing Treatment of Severe COVID-19 Patients

Prospective Study Finds Potential Utility of MeMed’s Host Immune Technology for Personalizing Treatment of Severe COVID-19 Patients

Rapid and Continuous Measurement of the Host-Immune Response with MeMed Key™ May Help Clinicians Predict COVID19 Disease Severity, Monitor Inflammatory Status and Guide Treatment Decisions   

HAIFA, Israel, July …

Read More